Eurocell AI Stock Analysis
Want to see GB:ECEL full AI Analyst Report?
Eurocell (ECEL) AI Stock Analysis
Eurocell
(LSE:ECEL)
The score is driven primarily by improving financial performance supported by steady free cash flow, though tempered by thinner margins versus prior peaks and higher leverage. Technicals add support with a clear uptrend and positive momentum indicators. Valuation is mixed (strong yield but a higher P/E), while the latest earnings call was constructive on momentum and cost-savings execution, balanced by pricing/inflation pressures and restructuring/ERP costs.
Eurocell (ECEL) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- GBP 138.00M
- Dividend Yield
- 4.71%
- Average Volume (3M)
- 168.86K
- Price to Earnings (P/E)
- 25.0
- Beta (1Y)
- 0.40
- Revenue Growth
- 10.68%
- EPS Growth
- -25.87%
- Country
- UK
- Employees
- 2,179
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Manufacturing - Miscellaneous
Eurocell Business Overview & Revenue Model
Company Description
Founded in 1974 and based in Alfreton, UK, Eurocell plc specializes in the manufacturing, distribution, and recycling of polyvinyl chloride (PVC) products for the building industry, specifically windows, doors, and roofline components, throughout the...
How the Company Makes Money
Eurocell makes money primarily by selling building products, with revenue generated through a combination of (1) manufacturing and selling uPVC profile systems and related components, and (2) distributing and retailing a wider range of building produ...
Eurocell Earnings Call Summary
The call was broadly positive, with revenue, adjusted operating profit, organic volumes, Q2 and second-half sales momentum, Alunet, branch initiatives, digital sales, shareholder returns and balance-sheet strength all improving. These positives were tempered by difficult market conditions, a 5% Profiles sales decline, competitive pricing pressure, inflation, restructuring and ERP charges, weaker cash generation versus the prior year and a safety-performance setback.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Eurocell expects full-year depreciation and amortization to be in the region of GBP 29 million, a slightly lower full-year tax rate of 24%, total CapEx of up to GBP 13 million, including GBP 3 million for strategic initiatives, GBP 3 million for site consolidation and GBP 3 million for facilities, welfare and safety improvements, and non-underlying ERP costs of approximately GBP 14 million for the 2024 to '27 period; the 3 major restructuring projects should deliver more than GBP 5 million of annual savings with GBP 2 million realized this year, the ERP transition is on track to take place at the end of the year, Power Up has a target of 15,000 by the year-end, Alunet is expected to sustain a low-teen operating margin, the company intends to continue share buybacks in due course subject to maintaining a strong financial position, and net debt is generally not to exceed 1x EBITDA unless there was a clear short-term deleveraging plan in place; management also said it remains committed to the GBP 250 million medium-term ambition and is confident it will deliver further progress in 2026.
Eurocell Financial Statement Overview
Summary
Operating momentum improved (revenue up 7.5% YoY and higher EBIT margin), and cash generation is solid with consistently positive free cash flow. Offsetting this, profitability remains well below prior-cycle peaks and leverage stepped up materially in 2025 (debt roughly matching equity), increasing balance-sheet risk.
Income Statement
63PositiveBalance Sheet
54NeutralCash Flow
71Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 415.50M | 403.50M | 357.90M | 364.50M | 381.20M | 339.80M |
| Gross Profit | 208.00M | 204.00M | 188.30M | 173.80M | 182.70M | 170.20M |
| EBITDA | 53.90M | 51.50M | 41.90M | 39.60M | 53.00M | 52.40M |
| Net Income | 5.60M | 9.60M | 10.50M | 9.60M | 19.70M | 21.10M |
Balance Sheet | ||||||
| Total Assets | 294.30M | 287.80M | 223.80M | 223.80M | 254.90M | 240.20M |
| Cash, Cash Equivalents and Short-Term Investments | 7.60M | 6.30M | 400.00K | 400.00K | 5.10M | 6.60M |
| Total Debt | 101.20M | 103.80M | 62.90M | 58.60M | 84.00M | 76.30M |
| Total Liabilities | 195.90M | 183.00M | 118.40M | 109.50M | 140.00M | 134.00M |
| Stockholders Equity | 98.40M | 104.80M | 105.40M | 114.30M | 114.90M | 106.20M |
Cash Flow | ||||||
| Free Cash Flow | 35.00M | 34.20M | 33.90M | 43.70M | 21.50M | 13.50M |
| Operating Cash Flow | 46.00M | 46.50M | 44.20M | 52.80M | 33.90M | 29.00M |
| Investing Cash Flow | -14.30M | -33.10M | -10.30M | -8.30M | -12.10M | -15.50M |
| Financing Cash Flow | -30.20M | -4.50M | -36.90M | -49.20M | -17.40M | -15.40M |
Eurocell Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ECEL, the sentiment is Neutral. The current price of 140.00 is below the 20-day moving average (MA) of 141.43, above the 50-day MA of 138.10, and above the 200-day MA of 117.70, indicating a neutral trend. The MACD of 0.85 indicates Positive momentum. The RSI at 48.86 is Neutral, neither overbought nor oversold. The STOCH value of 50.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:ECEL.
Eurocell Peers Comparison
Overall Rating
GB:FAN77Outperform
GB:ECEL68Neutral
GB:ALU62Neutral
GB:GEN61Neutral
GB:TPK56Neutral
GB:NXR49Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | GBP 1.26B | 20.03 | 20.92% | 1.78% | 15.67% | 50.33% | |
| 68Neutral | GBP 137.97M | 25.00 | 5.51% | 4.71% | 10.68% | -25.87% | |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| 62Neutral | GBP 103.39M | 14.06 | 16.97% | 3.84% | -5.55% | -21.94% | |
| 61Neutral | GBP 661.18M | 19.23 | 5.19% | 4.89% | 4.33% | -30.43% | |
| 56Neutral | GBP 1.35B | -7.91 | -9.63% | 1.80% | -0.49% | -208.37% | |
| 49Neutral | GBP 264.59M | 864.71 | 0.15% | 3.84% | 6.87% | -91.28% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:ECEL | Eurocell plc | 140.00 | 20.89 | 17.54% | |
| GB:ALU | Alumasc Group plc | 289.00 | 40.52 | 16.31% | |
| GB:NXR | Norcros plc | 294.00 | 14.77 | 5.29% | |
| GB:GEN | Genuit Group Plc | 263.80 | -27.72 | -9.51% | |
| GB:TPK | Travis Perkins | 640.50 | 75.74 | 13.41% | |
| GB:FAN | Volution Group Plc | 641.00 | 35.70 | 5.90% |
Eurocell Corporate Events
Eurocell Chair’s Associated Party Increases Shareholding in the Company
PositiveEurocell plc has disclosed that Karen Mapp, a person closely associated with non-executive chair Derek Mapp, purchased 35,000 ordinary shares in the company on 16 October 2026 at £1.37 per share on the London Stock Exchange. As a result of this trans...
Eurocell Non-Executive Director Rebalances Holding via Bed and ISA Deal
NeutralEurocell plc has disclosed a director dealing in its shares, with non-executive director Alison Littley executing a “Bed and ISA” transaction involving the sale of 14,121 ordinary shares at £1.42 each and the repurchase of 13,958 shares at the same p...
Eurocell CFO Exercises SAYE Options, Boosts Shareholding
PositiveEurocell plc disclosed that Chief Financial Officer Michael Scott has exercised options over 16,245 ordinary shares under the company’s Save As You Earn 2015 scheme at an exercise price of £1.108 per share. The shares, which vested in June 2026 follo...
Eurocell Chair’s Associated Party Increases Stake with Share Purchase
PositiveEurocell plc reported that Karen Mapp, a person closely associated with non-executive chair Derek Mapp, purchased 14,709 ordinary shares in the company at £1.35 per share on 22 September 2026. Following this transaction, Derek Mapp’s total reportable...
Eurocell Discloses Share Purchase by CEO’s Closely Associated Person
NeutralEurocell plc has reported a share purchase involving a person closely associated with its Chief Executive Officer, William Truman. The transaction reflects routine compliance with UK rules on disclosing dealings by senior management and their associa...
Eurocell Chair Derek Mapp Increases Stake with Share Purchase
PositiveEurocell plc has disclosed that its Non-Executive Chair of the Board, Derek Mapp, purchased 16,304 ordinary shares in the company on 3 September 2026 at a price of £1.22 per share. Following this transaction, Mapp’s total reportable holding has risen...
Eurocell Non-Executive Directors Lift Stakes Under Share Purchase Plan
PositiveEurocell has disclosed updated shareholdings for four non-executive directors following purchases made under its Non-executive Directors’ Share Purchase Plan on 1 September 2026. Chair Derek Mapp now holds 685,246 shares, while fellow non-executive d...
Eurocell lifts underlying profits and sales as restructuring reshapes business
PositiveEurocell reported a 6% rise in first-half revenue to £205.2m and a 10% increase in adjusted operating profit, driven by strong contributions from its Alunet division, improving branch network sales and tight cost control despite weak housing and RMI...
Eurocell Sets Investor Calls Around September Half-Year Results
NeutralEurocell plc will announce its half-year results for the six months to 30 June 2026 on 3 September, accompanied by an audiocast presentation for analysts and investors. The materials, including a recording of the presentation, will be made available...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 06, 2026
